ReviewTherapeutic advances in hematology2015

The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia.

Musa Yilmaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.